Rovalpituzumab is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3). Rovalpituzumab can be used to synthesize antibody-active molecule conjugates (ADCs). Rovalpituzumab has anticancer activity and is used to treat small cell lung canc
CAS Number:
[1613313-01-1]
Target:
Gamma-secretase
* VAT and and shipping costs not included. Errors and price changes excepted